Drägerwerk, healthcare

Drägerwerk stock trades at a 52-week high of EUR 124.60

Published on 09/23/2026 at 20:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock posted a 3.15 percent daily gain on September 23, 2026. Fiscal 2025 EBIT margin was 6.7 percent, while 2026 guidance spans 5.0 to 7.5 percent.

Moderne Intensivstation mit Beatmungsgerät und Patientenmonitoring in klinischer Umgebung
Drägerwerk AG & Co. KGaA zeigt moderne Intensivstation mit Beatmungsgeräten und Patientenmonitoring DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock was trading at EUR 124.60 on Xetra on September 23, 2026, up 3.15 percent from the previous close of EUR 120.80 and matching its 52-week high. The move gives the medical and safety technology company a market capitalization of EUR 2,337,496,000.

The 52-week high sets the marker

The reference price stands at the top of Drägerwerk's 52-week range of EUR 62.50 to EUR 124.60. That places the September 23 quotation EUR 3.80 above the previous close, a concrete one-session comparison that is more meaningful than a bare price level.

The company's latest financial framework also offers a numerical reference point. According to Drägerwerk, fiscal 2025 produced an EBIT margin of 6.7 percent and a gross margin of 45.2 percent.

2026 guidance spans 5.0 to 7.5 percent

For fiscal 2026, the company forecasts currency-adjusted revenue growth of 2.0 to 6.0 percent and an EBIT margin of 5.0 to 7.5 percent. The margin range therefore extends 1.7 percentage points below the 2025 result and 0.8 points above it, making execution and mix central to the earnings picture.

The same investor-relations information sets 2026 DVA guidance at EUR 20 million to EUR 120 million, versus EUR 90.1 million achieved in fiscal 2025. It also places planned investment at EUR 110 million to EUR 130 million, compared with EUR 103.1 million in 2025.

Stock stands at the yearly peak

Drägerwerk stock was trading at EUR 124.60 on Xetra on September 23, 2026. The quotation matches the 52-week high of EUR 124.60, while the daily gain of 3.15 percent places the session above the prior close of EUR 120.80.

Drägerwerk stock key facts

  • Company: Drägerwerk AG & Co. KGaA
  • Ticker: DRW3.DE
  • Trading venue: Xetra
  • Price: EUR 124.60 on September 23, 2026
  • Market capitalization: EUR 2,337,496,000 as of September 23, 2026
  • 52-week range: EUR 62.50-124.60 as of September 23, 2026
  • Sector / Industry: Healthcare / Medical Devices

Disclaimer...

en | boerse | 70169753 |